Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Litvak

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Antisense & Nucleic Acid Drug Development|January 1, 1996
Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptaseC Boiziau, L Tarrago-Litvak, N D Sinha, et al.
Expert Opinion on Therapeutic Targets|September 12, 2002
HIV-1 integrase and RNase H activities as therapeutic targetsM L Andréola, V Richard De Soultrait, M Fournier, et al.
Journal of Molecular Biology|July 5, 1990
Direct protein sequencing of wheat mitochondrial ATP synthase subunit 9 confirms RNA editing in plantsP V Graves, D Bégu, J Velours, et al.
Gene|April 25, 2000
Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeastV Parissi, A Caumont, V Richard de Soultrait, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cellsB Bordier, M Perala-Heape, G Degols, et al.
Nucleic Acids Research|November 25, 1998
Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcriptionF Boulmé, F Freund, S Moreau, et al.
European Journal of Biochemistry|September 15, 1996
Interaction of human immunodeficiency virus type 1 reverse transcriptase with primer tRNALys3 and affinity modification of the enzyme by tRNALys3 derivativesG A Nevinsky, O D Zakharova, M Fournier, et al.
Journal of Molecular Biology|July 5, 1992
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotidesL Sarih-Cottin, B Bordier, K Musier-Forsyth, et al.
Journal of Virology|November 2, 2001
Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60V Parissi, C Calmels, V R De Soultrait, et al.
Journal of Molecular Biology|January 26, 1999
Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3E Dufour, J Reinbolt, M Castroviejo, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Antisense & Nucleic Acid Drug Development|January 1, 1996
Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptaseC Boiziau, L Tarrago-Litvak, N D Sinha, et al.
Expert Opinion on Therapeutic Targets|September 12, 2002
HIV-1 integrase and RNase H activities as therapeutic targetsM L Andréola, V Richard De Soultrait, M Fournier, et al.
Journal of Molecular Biology|July 5, 1990
Direct protein sequencing of wheat mitochondrial ATP synthase subunit 9 confirms RNA editing in plantsP V Graves, D Bégu, J Velours, et al.
Gene|April 25, 2000
Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeastV Parissi, A Caumont, V Richard de Soultrait, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cellsB Bordier, M Perala-Heape, G Degols, et al.
Nucleic Acids Research|November 25, 1998
Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcriptionF Boulmé, F Freund, S Moreau, et al.
European Journal of Biochemistry|September 15, 1996
Interaction of human immunodeficiency virus type 1 reverse transcriptase with primer tRNALys3 and affinity modification of the enzyme by tRNALys3 derivativesG A Nevinsky, O D Zakharova, M Fournier, et al.
Journal of Molecular Biology|July 5, 1992
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotidesL Sarih-Cottin, B Bordier, K Musier-Forsyth, et al.
Journal of Virology|November 2, 2001
Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60V Parissi, C Calmels, V R De Soultrait, et al.
Journal of Molecular Biology|January 26, 1999
Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3E Dufour, J Reinbolt, M Castroviejo, et al.
Pageof 17